MediWound Ltd. (MDWD) stock
MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$12.97−0.85 (-6.15%)
Close on Nov 12, 2026Market cap $166.47MP/E –Yield –
MediWound operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -149.0%, against -95.9% the year before. The highest annual figure on record is 14.1% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -149.0% | −53.0 |
| FY2024 | Dec 31, 2024 | -95.9% | −14.1 |
| FY2023 | Dec 31, 2023 | -81.8% | −50.3 |
| FY2022 | Dec 31, 2022 | -31.5% | +15.7 |
| FY2021 | Dec 31, 2021 | -47.2% | −6.6 |
| FY2020 | Dec 31, 2020 | -40.6% | −54.8 |
| FY2019 | Dec 31, 2019 | 14.1% | +130.6 |
| FY2018 | Dec 31, 2018 | -116.4% | +431.9 |
| FY2017 | Dec 31, 2017 | -548.4% | +745.3 |
| FY2016 | Dec 31, 2016 | -1293.6% | +2238.3 |
| FY2015 | Dec 31, 2015 | -3531.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -305.9% | −227.2 |
| Q2 FY2025 | Jun 30, 2025 | -100.1% | −52.3 |
| Q2 FY2024 | Jun 30, 2024 | -88.6% | −21.4 |
| Q2 FY2023 | Jun 30, 2023 | -84.0% | −151.1 |
| Q2 FY2022 | Jun 30, 2022 | -78.7% | +240.0 |
| Q2 FY2021 | Jun 30, 2021 | -47.8% | +491.2 |
| Q2 FY2020 | Jun 30, 2020 | -67.2% | – |
| Q2 FY2019 | Jun 30, 2019 | 67.2% | – |
| Q2 FY2018 | Jun 30, 2018 | -318.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -539.0% | – |
See a number that looks wrong?